Alivus Life Sciences Reports Record Financial Performance, Boosts Evaluation Score in May 2025
Alivus Life Sciences has announced strong financial results for the quarter ending March 2025, achieving record quarterly net sales of Rs 649.55 crore and an operating profit of Rs 198.44 crore. The profit after tax reached Rs 141.87 crore, reflecting significant growth in earnings per share.
Alivus Life Sciences, a midcap player in the Pharmaceuticals & Biotechnology sector, has reported its financial results for the quarter ending March 2025, declaring them on May 15, 2025. The company has experienced notable financial performance during this period, with a significant adjustment in its evaluation score, rising to 10 from 4 over the last three months.The financial data reveals that Alivus Life achieved its highest quarterly net sales in the last five quarters, amounting to Rs 649.55 crore. This positive trend is mirrored in the operating profit, which also reached a peak of Rs 198.44 crore, indicating enhanced operational efficiency with an operating profit margin of 30.55%.
Additionally, the profit before tax (PBT) stood at Rs 181.20 crore, reflecting a growth of 28.3% compared to the average of the previous four quarters. The profit after tax (PAT) also reached a record high of Rs 141.87 crore, with a growth rate of 28.5% over the same comparative period. Furthermore, earnings per share (EPS) hit Rs 11.58, showcasing the company's ability to generate higher earnings for its shareholders.
Overall, Alivus Life Sciences has demonstrated strong financial metrics in this quarter, leading to a revision in its score.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
